No (N=64) |
Yes (N=13) |
P-value | |
---|---|---|---|
Age (years) | |||
Mean (SD) | 55.0 (9.98) | 56.4 (13.4) | 0.314 |
Median [Min, Max] | 54.5 [30.0, 82.0] | 58.0 [24.0, 79.0] | |
Operation_history | |||
Direct_surgery | 49 (76.6%) | 4 (30.8%) | 0.00348 |
Surgery_after_neoadjuvant | 15 (23.4%) | 9 (69.2%) | |
Type | |||
CCC | 1 (1.6%) | 0 (0%) | 0.847 |
EC | 2 (3.1%) | 1 (7.7%) | |
HGSC | 57 (89.1%) | 12 (92.3%) | |
LGSC | 2 (3.1%) | 0 (0%) | |
MC | 1 (1.6%) | 0 (0%) | |
Missing | 1 (1.6%) | 0 (0%) | |
Clinical_stage | |||
I | 1 (1.6%) | 0 (0%) | 0.0915 |
II | 4 (6.3%) | 0 (0%) | |
III | 34 (53.1%) | 3 (23.1%) | |
IV | 25 (39.1%) | 10 (76.9%) | |
TMB_group | |||
High | 2 (3.1%) | 2 (15.4%) | 0.266 |
Low | 61 (95.3%) | 11 (84.6%) | |
Missing | 1 (1.6%) | 0 (0%) | |
Planting_metastasis | |||
No | 5 (7.8%) | 1 (7.7%) | 1 |
Yes | 59 (92.2%) | 12 (92.3%) | |
Lymph.node_metastasis | |||
No | 26 (40.6%) | 4 (30.8%) | 0.725 |
Yes | 38 (59.4%) | 9 (69.2%) | |
Type_group | |||
HGSC | 57 (89.1%) | 12 (92.3%) | 1 |
Non_HGSC | 7 (10.9%) | 1 (7.7%) |